Kyverna Therapeutics Inc Price to Free Cash Flow Ratio (PFCF) Ratios, (KYTX) Valuation Ranking and Trends, Fundamental Ratios

KYTX Price to Free Cash Flow Ratio	(Mar 31 2025)	(Dec 31 2024)	(Sep 30 2024)
Free Cash Flow Trailing 12 Months	I. Quarter	IV. Quarter	III. Quarter
Price to Free Cash Flow (TTM) Ratio	current -	-	-	-	-
Free Cash flow TTM Y / Y Change	- %	- %	- %	- %	- %
Free Cash flow Y / Y Change	- %	- %	- %	- %	- %
Stock performance	to date -0.97 %	-33.74 %	-8.08 %

Price to Free Cash Flow ratio Comment

Kyverna Therapeutics Inc recorded Cash outflow in the trailing twelve months.

What is Price to Free Cash Flow Ratio?
Valuation within Biotechnology & Pharmaceuticals Industry

Price to Free Cash Flow ratio Company Ranking
Within:	No.
Industry	#2
Sector	#9
S&P 500	#54

Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com